The global pharmaceutical drug delivery market is projected to reach $2 trillion by 2025.
Although the industry is growing day by day due to the ever-increasing demand for its services, there is also the extra load to produce more medicine for more people in the coming years. The pressure to bring high-quality medicine to people and invent and distribute new therapies means pharma and life sciences companies have to achieve real-time visibility into demand, ensure optimum level of material for drug production, and maintain the right level of inventory. In addition, they need to constantly streamline the R&D process, ensure quality control at each stage of the development lifecycle, and ensure contracts are signed in time.
But despite the need to keep pace with increasing market demands, evolving legislations, and supply chain requirements to stay competitive, inefficient contract management and logistics bottlenecks greatly impact timelines, causing delays in clinical trials which invariably delay patients receiving life-saving treatments. This makes high quality and low risk the need of the hour. Read on to learn about the challenges plaguing the pharma and life sciences industry and uncover top reasons why companies are considering DevOps to overcome those challenges.
Despite the unprecedented growth rate, the pharma and life sciences industry has been facing its share of challenges: right from sustaining their business to driving innovation and keeping up with the growing demands of their customers. Here’s looking at 6 of the top challenges:
The adoption of DevOps by pharma and life sciences companies is driven primarily by the need to enhance operational efficiency, accelerate time-to-market, and improve customer experiences.
Here’s how DevOps helps overcome the challenges faced by pharma and life sciences companies:
The Significance of DevSecOps
Although DevOps is helping pharma and life services companies overcome many of the challenges they’re facing today, introducing the element of security through DevSecOps can further up their game. By introducing security early in the development lifecycle, pharma companies can identify and resolve issues quicker and pave the way for better risk management.
Since DevSecOps makes security everyone’s responsibility, companies can be more confident about the products they introduce into the market while also protecting their business against cyber-attacks, breaches, and misuse.
Pharma and life sciences companies often find themselves struggling to align their business needs with the specific requirements of customers. Since considerable development effort goes into the development of medical devices and the support of clinical trial applications, a robust software development process like DevOps can pave the way for seamless communication and collaboration, end-to-end tracking, complete visibility into the development process, security across the delivery lifecycle, and eventually an extremely high-quality product.